Takehiro Taninaga

Efficacy and Safety of Transitioning to Lemborexant from Z-drug, Suvorexant, and Ramelteon in Japanese Insomnia Patients: An Open-label, Multicenter Study

Motohiro Ozone, Susumu Hirota, Yu Ariyoshi et al. · Advances in Therapy · 2024 · 20 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Comparison of the treatment effectiveness between lemborexant and zolpidem tartrate extended-release for insomnia disorder subtypes defined based on polysomnographic findings

Yuichi Inoue, Maika Nishida, Naoki Kubota et al. · Journal of Clinical Sleep Medicine · 2022 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial

H. Tamai, Kei Ikeda, Toshiaki Miyamoto et al. · The Lancet Rheumatology · 2023 · 12 citations

Life Sciences, Immunology, Pharmacology +14